Is it safe to discontinue Deplin (L‑methylfolate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Discontinuing Deplin (L-methylfolate) is Generally Safe

Yes, it is safe to stop Deplin (L-methylfolate), as it is a medical food supplement rather than a pharmaceutical antidepressant and does not carry the withdrawal risks associated with traditional psychiatric medications.

Key Safety Considerations

L-methylfolate has an excellent safety profile with no evidence of withdrawal syndromes or discontinuation effects:

  • No withdrawal symptoms reported: Unlike SSRIs or other antidepressants, L-methylfolate does not cause discontinuation syndrome 1, 2
  • Well-tolerated across populations: Safety studies show adverse event rates comparable to placebo, with the most common side effects being impaired sleep (rare) and increased anxiety (very rare) 3
  • No serious adverse events: Preclinical toxicity studies at doses up to 400 mg/kg/day showed no treatment-related toxicity, and effects were fully reversible after stopping 4, 5

Clinical Context for Discontinuation

When Stopping Makes Sense:

  • Lack of efficacy: If you've been on L-methylfolate 15 mg/day for 60-90 days without improvement in depressive symptoms
  • Achieved remission: Some patients may consider discontinuation after sustained recovery, though this should be discussed with your provider
  • Side effects: Though rare (10% incidence), if experiencing adverse effects 3

Important Caveats:

  • Don't confuse with your antidepressant: The FDA drug label information provided 6 refers to diclofenac (an NSAID), NOT Deplin. This appears to be a database error. Deplin has none of these cardiovascular, hepatic, or renal risks.
  • Consider why it was started: If prescribed as adjunctive therapy for SSRI-resistant depression, stopping L-methylfolate means losing potential augmentation benefits (15 mg/day showed significant efficacy with NNT=6) 2
  • Coordinate with your provider: While physically safe to stop, your overall depression treatment plan may need adjustment

Practical Approach to Discontinuation

You can stop L-methylfolate abruptly without tapering:

  • No gradual dose reduction needed
  • No monitoring required after discontinuation
  • Effects (if any) will dissipate as the supplement clears your system

However, inform your prescribing physician so they can:

  • Monitor your depression symptoms for potential worsening
  • Consider alternative augmentation strategies if needed
  • Adjust your overall treatment plan accordingly

The evidence consistently shows L-methylfolate is a medical food with minimal risk, making discontinuation straightforward from a safety standpoint 1, 3, 2, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.